Logo image of CTZ.CA

NAMSYS INC (CTZ.CA) Stock Fundamental Analysis

TSX-V:CTZ - TSX Venture Exchange - CA6300001071 - Common Stock - Currency: CAD

1.68  0 (0%)

Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to CTZ. CTZ was compared to 62 industry peers in the Software industry. CTZ gets an excellent profitability rating and is at the same time showing great financial health properties. CTZ is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CTZ had positive earnings in the past year.
CTZ had a positive operating cash flow in the past year.
Of the past 5 years CTZ 4 years were profitable.
CTZ had a positive operating cash flow in 4 of the past 5 years.
CTZ.CA Yearly Net Income VS EBIT VS OCF VS FCFCTZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1M -1M 2M

1.2 Ratios

The Return On Assets of CTZ (22.74%) is better than 93.55% of its industry peers.
CTZ's Return On Equity of 26.35% is amongst the best of the industry. CTZ outperforms 90.32% of its industry peers.
Looking at the Return On Invested Capital, with a value of 22.08%, CTZ belongs to the top of the industry, outperforming 95.16% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CTZ is significantly above the industry average of 12.92%.
The last Return On Invested Capital (22.08%) for CTZ is above the 3 year average (20.76%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 22.74%
ROE 26.35%
ROIC 22.08%
ROA(3y)20.74%
ROA(5y)14.37%
ROE(3y)23.07%
ROE(5y)12.84%
ROIC(3y)20.76%
ROIC(5y)24%
CTZ.CA Yearly ROA, ROE, ROICCTZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200 250

1.3 Margins

CTZ's Profit Margin of 32.89% is amongst the best of the industry. CTZ outperforms 93.55% of its industry peers.
CTZ's Profit Margin has been stable in the last couple of years.
The Operating Margin of CTZ (38.64%) is better than 98.39% of its industry peers.
In the last couple of years the Operating Margin of CTZ has declined.
CTZ's Gross Margin of 63.58% is fine compared to the rest of the industry. CTZ outperforms 67.74% of its industry peers.
In the last couple of years the Gross Margin of CTZ has remained more or less at the same level.
Industry RankSector Rank
OM 38.64%
PM (TTM) 32.89%
GM 63.58%
OM growth 3Y0.73%
OM growth 5Y-2.15%
PM growth 3Y6.28%
PM growth 5Y-0.63%
GM growth 3Y1.23%
GM growth 5Y-1.35%
CTZ.CA Yearly Profit, Operating, Gross MarginsCTZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

10

2. Health

2.1 Basic Checks

CTZ has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, CTZ has less shares outstanding
CTZ has less shares outstanding than it did 5 years ago.
CTZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CTZ.CA Yearly Shares OutstandingCTZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CTZ.CA Yearly Total Debt VS Total AssetsCTZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

An Altman-Z score of 22.10 indicates that CTZ is not in any danger for bankruptcy at the moment.
CTZ's Altman-Z score of 22.10 is amongst the best of the industry. CTZ outperforms 98.39% of its industry peers.
CTZ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 22.1
ROIC/WACC2.81
WACC7.86%
CTZ.CA Yearly LT Debt VS Equity VS FCFCTZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M

2.3 Liquidity

A Current Ratio of 7.27 indicates that CTZ has no problem at all paying its short term obligations.
With an excellent Current ratio value of 7.27, CTZ belongs to the best of the industry, outperforming 91.94% of the companies in the same industry.
CTZ has a Quick Ratio of 7.27. This indicates that CTZ is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 7.27, CTZ belongs to the best of the industry, outperforming 91.94% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.27
Quick Ratio 7.27
CTZ.CA Yearly Current Assets VS Current LiabilitesCTZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

4

3. Growth

3.1 Past

CTZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.33%, which is quite impressive.
CTZ shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.78% yearly.
CTZ shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.46%.
CTZ shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.68% yearly.
EPS 1Y (TTM)43.33%
EPS 3Y17.83%
EPS 5Y9.78%
EPS Q2Q%65.58%
Revenue 1Y (TTM)16.46%
Revenue growth 3Y11.2%
Revenue growth 5Y10.68%
Sales Q2Q%22.55%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CTZ.CA Yearly Revenue VS EstimatesCTZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.67, the valuation of CTZ can be described as rather expensive.
CTZ's Price/Earnings ratio is rather cheap when compared to the industry. CTZ is cheaper than 82.26% of the companies in the same industry.
CTZ is valuated rather cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.67
Fwd PE N/A
CTZ.CA Price Earnings VS Forward Price EarningsCTZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

CTZ's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CTZ is cheaper than 72.58% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CTZ is valued a bit cheaper than 79.03% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.6
EV/EBITDA 10.41
CTZ.CA Per share dataCTZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

The excellent profitability rating of CTZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.91
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CTZ!.
Industry RankSector Rank
Dividend Yield N/A

NAMSYS INC

TSX-V:CTZ (7/3/2025, 7:00:00 PM)

1.68

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)06-26 2025-06-26
Earnings (Next)09-23 2025-09-23
Inst Owners21.38%
Inst Owner ChangeN/A
Ins Owners8.18%
Ins Owner ChangeN/A
Market Cap45.12M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.05
Dividend Growth(5Y)N/A
DP57.06%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 18.67
Fwd PE N/A
P/S 6.27
P/FCF 15.6
P/OCF 15.55
P/B 5.02
P/tB 5.02
EV/EBITDA 10.41
EPS(TTM)0.09
EY5.36%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.11
FCFY6.41%
OCF(TTM)0.11
OCFY6.43%
SpS0.27
BVpS0.33
TBVpS0.33
PEG (NY)N/A
PEG (5Y)1.91
Profitability
Industry RankSector Rank
ROA 22.74%
ROE 26.35%
ROCE 30.96%
ROIC 22.08%
ROICexc 1156.7%
ROICexgc 1156.7%
OM 38.64%
PM (TTM) 32.89%
GM 63.58%
FCFM 40.18%
ROA(3y)20.74%
ROA(5y)14.37%
ROE(3y)23.07%
ROE(5y)12.84%
ROIC(3y)20.76%
ROIC(5y)24%
ROICexc(3y)454.3%
ROICexc(5y)N/A
ROICexgc(3y)454.3%
ROICexgc(5y)N/A
ROCE(3y)29.1%
ROCE(5y)33.64%
ROICexcg growth 3Y-15.99%
ROICexcg growth 5Y13.62%
ROICexc growth 3Y-15.99%
ROICexc growth 5Y13.62%
OM growth 3Y0.73%
OM growth 5Y-2.15%
PM growth 3Y6.28%
PM growth 5Y-0.63%
GM growth 3Y1.23%
GM growth 5Y-1.35%
F-Score9
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 133.8%
Cap/Sales 0.13%
Interest Coverage 250
Cash Conversion 104.06%
Profit Quality 122.19%
Current Ratio 7.27
Quick Ratio 7.27
Altman-Z 22.1
F-Score9
WACC7.86%
ROIC/WACC2.81
Cap/Depr(3y)76.27%
Cap/Depr(5y)51.64%
Cap/Sales(3y)0.13%
Cap/Sales(5y)0.16%
Profit Quality(3y)96.79%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)43.33%
EPS 3Y17.83%
EPS 5Y9.78%
EPS Q2Q%65.58%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.46%
Revenue growth 3Y11.2%
Revenue growth 5Y10.68%
Sales Q2Q%22.55%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.58%
EBIT growth 3Y12.01%
EBIT growth 5Y8.3%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.69%
FCF growth 3YN/A
FCF growth 5Y12.45%
OCF growth 1Y59.79%
OCF growth 3YN/A
OCF growth 5Y12.31%